{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:13:18Z","timestamp":1788484398784,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.revmed.2026.07.015","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:12:47Z","timestamp":1786450367000},"page":"474-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rituximab-induced hypogammaglobulinemia in autoimmune cytopenia and associated diseases"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2814-9830","authenticated-orcid":false,"given":"Jonathan","family":"Sormani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7707-0918","authenticated-orcid":false,"given":"David","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Dechomet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3070-3842","authenticated-orcid":false,"given":"Pascal","family":"Seve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Hot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Koppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3460-2507","authenticated-orcid":false,"given":"Sandrine","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Confavreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Ghesquieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Benezech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quitterie","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.revmed.2026.07.015_bib0210","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3324\/haematol.2019.243543","article-title":"The regulation and function of CD20: an \u201cenigma\u201d of B-cell biology and targeted therapy","volume":"105","author":"Pavlasova","year":"2020","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.revmed.2026.07.015_bib0215","first-page":"676","article-title":"Mechanisms of action of CD20 antibodies","volume":"2","author":"Boross","year":"2012","journal-title":"Am J Cancer Res"},{"issue":"47","key":"10.1016\/j.revmed.2026.07.015_bib0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.revmed.2026.07.015_bib0225","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/sj.leu.2402226","article-title":"CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8+ cytotoxic T cells","volume":"15","author":"Selenko","year":"2001","journal-title":"Leukemia"},{"issue":"No\u00a0284","key":"10.1016\/j.revmed.2026.07.015_bib0230","first-page":"2","article-title":"FDA approves new kind of lymphoma treatment. Food and Drug Administration","author":"James","year":"1997","journal-title":"AIDS Treat News"},{"issue":"8","key":"10.1016\/j.revmed.2026.07.015_bib0235","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.revmed.2026.07.015_bib0240","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.revmed.2026.07.015_bib0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.revmed.2026.07.015_bib0250","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2026.07.015_bib0255","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3389\/fimmu.2019.01990","article-title":"Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders","volume":"10","author":"Kaegi","year":"2019","journal-title":"Front Immunol"},{"issue":"Suppl 124-2","key":"10.1016\/j.revmed.2026.07.015_bib0260","first-page":"188","article-title":"Rituximab-associated hypogammaglobulinaemia in ANCA-associated vasculitis and connective tissue diseases: a longitudinal observational study","volume":"38","author":"Padoan","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2026.07.015_bib0265","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jaci.2021.03.041","article-title":"Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients","volume":"148","author":"Labrosse","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.revmed.2026.07.015_bib0270","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10875-024-01773-y","article-title":"Hypogammaglobulinemia and infection events in patients with autoimmune diseases treated with rituximab: 10 years real-life experience","volume":"44","author":"Nie","year":"2024","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.revmed.2026.07.015_bib0275","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00467-022-05652-9","article-title":"The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome","volume":"38","author":"Inoki","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.revmed.2026.07.015_bib0280","doi-asserted-by":"crossref","first-page":"1380654","DOI":"10.3389\/fneur.2024.1380654","article-title":"Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients","volume":"15","author":"Elgenidy","year":"2024","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.revmed.2026.07.015_bib0285","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jaci.2022.01.025","article-title":"Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees","volume":"149","author":"Otani","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2026.07.015_bib0290","article-title":"Therapeutic B-cell depletion: Mechanisms, clinical applications, and implications for secondary immunodeficiency","author":"Elmoursi","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2026.07.015_bib0295","doi-asserted-by":"crossref","first-page":"103130","DOI":"10.1016\/j.jaut.2023.103130","article-title":"Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study","volume":"142","author":"Liberatore","year":"2024","journal-title":"J Autoimmun"},{"issue":"8","key":"10.1016\/j.revmed.2026.07.015_bib0300","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/rheumatology\/keac716","article-title":"Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study","volume":"62","author":"Podest\u00e0","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.revmed.2026.07.015_bib0305","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s10157-020-01858-z","article-title":"Profound effect of post-rituximab mycophenolate mofetil administration for persistent hypogammaglobulinemia in young children with steroid-dependent nephrotic syndrome","volume":"24","author":"Fujinaga","year":"2020","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.revmed.2026.07.015_bib0310","doi-asserted-by":"crossref","first-page":"100648","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev"},{"issue":"22","key":"10.1016\/j.revmed.2026.07.015_bib0315","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.revmed.2026.07.015_bib0320","doi-asserted-by":"crossref","first-page":"e184169","DOI":"10.1001\/jamanetworkopen.2018.4169","article-title":"Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia","volume":"1","author":"Barmettler","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"23","key":"10.1016\/j.revmed.2026.07.015_bib0325","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.revmed.2026.07.015_bib0330","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.revmed.2026.07.015_bib0335","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2026.07.015_bib0340","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev-cellbio-011620-034148","article-title":"B Cell immunosenescence","volume":"36","author":"Frasca","year":"2020","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.revmed.2026.07.015_bib0345","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0009-8981(02)00418-7","article-title":"Establishment of age-dependent reference values for IgA subclasses","volume":"328","author":"Schauer","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.revmed.2026.07.015_bib0350","series-title":"Proteins in clinical and laboratory medicine: use and assessment of clinical laboratory results","author":"Thomas","year":"2008"},{"key":"10.1016\/j.revmed.2026.07.015_bib0355","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). 2017."},{"issue":"6","key":"10.1016\/j.revmed.2026.07.015_bib0360","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.anai.2023.01.018","article-title":"Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab","volume":"130","author":"Athni","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.revmed.2026.07.015_bib0365","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2019-eular.3767","article-title":"Ab0473 hypogammaglobulinemia and infections in rheumatologic patients treated with rituximab","volume":"78","author":"Fierro","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.revmed.2026.07.015_bib0370","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13075-017-1306-0","article-title":"B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients","volume":"19","author":"Thiel","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.revmed.2026.07.015_bib0375","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaip.2019.07.032","article-title":"Rituximab unveils hypogammaglobulinemia and immunodeficiency in children with autoimmune cytopenia","volume":"8","author":"Ottaviano","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.revmed.2026.07.015_bib0380","doi-asserted-by":"crossref","first-page":"671503","DOI":"10.3389\/fimmu.2021.671503","article-title":"Rituximab associated hypogammaglobulinemia in autoimmune disease","volume":"12","author":"Tieu","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.revmed.2026.07.015_bib0385","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3899\/jrheum.090856","article-title":"Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials","volume":"37","author":"van Vollenhoven","year":"2010","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.revmed.2026.07.015_bib0390","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/rheumatology\/keu194","article-title":"Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis","volume":"53","author":"Besada","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.revmed.2026.07.015_bib0395","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41572-024-00566-2","article-title":"Autoimmune haemolytic anaemias","volume":"10","author":"Michel","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"22","key":"10.1016\/j.revmed.2026.07.015_bib0400","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","article-title":"Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France","volume":"124","author":"Moulis","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.revmed.2026.07.015_bib0405","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.clinbiochem.2015.03.014","article-title":"Value of reflex testing based on hypogammaglobulinemia as demonstrated in serum protein electrophoresis","volume":"48","author":"Chan","year":"2015","journal-title":"Clin Biochem"},{"issue":"8","key":"10.1016\/j.revmed.2026.07.015_bib0410","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s10875-023-01536-1","article-title":"Screening for Antibody deficiencies in adults by serum electrophoresis and calculated globin","volume":"43","author":"de Toledo Piza","year":"2023","journal-title":"J Clin Immunol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326006740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326006740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:41:44Z","timestamp":1788482504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866326006740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0248866326006740"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2026.07.015","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab-induced hypogammaglobulinemia in autoimmune cytopenia and associated diseases","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2026.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}